September 17, 2014 7:56 PM ET

Biotechnology

Company Overview of MIGENIX Corp.

Company Overview

MIGENIX Corp. provides research and development services for drugs used in the treatment of medical conditions related to mitochondrial dysfunction. The company has clinical and preclinical product candidates for neurological, metabolic, and degenerative diseases. MIGENIX Corp. develops MITO-4509 for Alzheimer’s disease; MITO-4565 for Glaucoma; and MITO-4042 for Arthritis. The company formerly known as Mitokor, Inc. and changed its name to MIGENIX Corp. in September 2004. The company was founded in 1991 and is based in San Diego, California. As of August 31, 2004, MIGENIX Corp. operates as a subsidiary of Metro Vancouver Properties Corp.

11494 Sorrento Valley Road

San Diego, CA 92121

United States

Founded in 1991

129 Employees

Phone:

858-793-7800

Fax:

858-793-7805

Key Executives for MIGENIX Corp.

MIGENIX Corp. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Viamet Pharmaceuticals, Inc. United States
SymbioCellTech, LLC United States
Epeius Biotechnologies Corporation United States
SEKRIS Biomedical, Inc. United States
ImmuMed, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIGENIX Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.